Chris A Rallis Fennec Pharmaceuticals Inc. (FENC) insider trading activity

Chris A Rallis is of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 48,623 shares of FENC, which is worth approximately $225,610. The most recent transaction as insider was on Oct 08, 2024, when has been sold 1,406 shares (Common Shares) at a price of $4.53 per share, resulting in proceeds of $6,369. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.6K

4.66% 3M change

12.99% 12M change

Total Value Held $225,610

CHRIS A RALLIS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 08 2024	SELL Open market or private sale	$6,369 $4.53 p/Share	1,406 Reduced 2.81%	48,623 Common Shares
Oct 08 2024	BUY Exercise of conversion of derivative security	$4,998 $2.55 p/Share	1,960 Added 3.77%	50,029 Common Shares
Jul 05 2024	SELL Open market or private sale	$7,073 $6.03 p/Share	1,173 Reduced 2.46%	46,457 Common Shares
Jul 05 2024	BUY Exercise of conversion of derivative security	$4,999 $2.79 p/Share	1,792 Added 3.63%	47,630 Common Shares
Apr 15 2024	SELL Open market or private sale	$8,360 $10.45 p/Share	800 Reduced 1.77%	44,449 Common Shares
Apr 15 2024	BUY Exercise of conversion of derivative security	$14,515 $10.45 p/Share	1,389 Added 2.94%	45,838 Common Shares
Mar 26 2024	SELL Open market or private sale	$23,190 $10.97 p/Share	2,114 Reduced 4.91%	40,920 Common Shares
Mar 26 2024	BUY Exercise of conversion of derivative security	$9,999 $2.31 p/Share	4,329 Added 8.73%	45,249 Common Shares
Dec 26 2023	SELL Open market or private sale	$15,151 $10.9 p/Share	1,390 Reduced 3.01%	44,788 Common Shares
Dec 26 2023	BUY Exercise of conversion of derivative security	$4,998 $1.59 p/Share	3,144 Added 6.37%	46,178 Common Shares
Nov 20 2023	SELL Open market or private sale	$2,219 $8.25 p/Share	269 Reduced 0.62%	43,034 Common Shares
Aug 18 2023	SELL Open market or private sale	$5,283 $7.85 p/Share	673 Reduced 1.53%	43,303 Common Shares
Jul 24 2023	SELL Open market or private sale	$55,523 $8.17 p/Share	6,796 Reduced 13.39%	43,976 Common Shares
Jul 24 2023	BUY Exercise of conversion of derivative security	$11,999 $0.72 p/Share	16,666 Added 24.71%	50,772 Common Shares
Jul 06 2023	SELL Open market or private sale	$18,693 $8.47 p/Share	2,207 Reduced 7.11%	28,826 Common Shares
Jul 06 2023	BUY Exercise of conversion of derivative security	$5,068 $0.96 p/Share	5,280 Added 13.41%	34,106 Common Shares
May 19 2023	SELL Open market or private sale	$12,938 $7.36 p/Share	1,758 Reduced 5.36%	31,033 Common Shares
Apr 17 2023	SELL Payment of exercise price or tax liability	$8,223 $8.34 p/Share	986 Reduced 2.92%	32,791 Common Shares
Apr 17 2023	BUY Exercise of conversion of derivative security	$4,998 $2.94 p/Share	1,700 Added 4.79%	33,777 Common Shares
Mar 03 2023	SELL Payment of exercise price or tax liability	$19,788 $9.09 p/Share	2,177 Reduced 6.36%	32,077 Common Shares
Mar 03 2023	BUY Exercise of conversion of derivative security	$9,998 $2.4 p/Share	4,166 Added 10.86%	34,184 Common Shares
Nov 17 2022	SELL Open market or private sale	$2,660 $7.99 p/Share	333 Reduced 1.1%	30,018 Common Shares
Oct 20 2022	SELL Payment of exercise price or tax liability	$17,082 $8.26 p/Share	2,068 Reduced 6.38%	30,351 Common Shares
Oct 20 2022	BUY Exercise of conversion of derivative security	$5,000 $1.05 p/Share	4,762 Added 12.81%	32,419 Common Shares
Jul 18 2022	SELL Payment of exercise price or tax liability	$29,339 $6.7 p/Share	4,379 Reduced 13.67%	27,657 Common Shares

CAR

Chris A Rallis

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FENC shares.

Notify only if

Value

Insider Trading

Get notified when an Fennec Pharmaceuticals Inc. insider buys or sells FENC shares.

Notify only if

Operation

Value

Type

News

Receive news related to FENNEC PHARMACEUTICALS INC.

Track Activities on FENC

Account